This federal contract award, valued at $23,983.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SURECLICK medication, with an ultimate completion date of October 29, 2024.
The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract has no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the contract involves the delivery of various medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, across multiple therapeutic domains to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/2/25, 12:05 AM